Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes

被引:159
作者
Amicone, L
Spagnoli, FM
Spath, G
Giordano, S
Tommasini, C
Bernardini, S
DeLuca, V
DellaRocca, C
Weiss, MC
Comoglio, PM
Tripodi, M
机构
[1] UNIV ROMA LA SAPIENZA,SEZ ANAT PATOL,DIPARTIMENTO MED SPERIMENTALE & PATOL,ROME,ITALY
[2] UNIV TURIN,INST CANC RES,IRCC,TURIN,ITALY
[3] INST PASTEUR,URA CNRS 1149,UNITE GENET DIFFERENCIAT,PARIS,FRANCE
关键词
apoptosis protection; cell polarity; immortalized hepatocytes; Met;
D O I
10.1093/emboj/16.3.495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor induces proliferation, motility and differentiation of epithelial cells through the tyrosine kinase receptor encoded by the MET protooncogene. The cytoplasmic portion of Met (referred to as cyto-Met) is activated but only weakly transforming. In order to determine the effect of activated Met on hepatocytes, we have targeted truncated Met expression to the liver by incorporating the cDNA into a vector carrying the entire human a-1-antitrypsin transcriptional unit, Transgenic expression in the liver of truncated human Met, containing the regulatory and the catalytic cytoplasmic domains, renders hepatocytes constitutively resistant to apoptosis and reproducibly permits immortalization. The emerging stable cell lines are not transformed and maintain a highly differentiated phenotype judged by the retention of epithelial cell polarity and the expression of hepatocyte-enriched transcription factors as well as hepatic products.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 64 条
  • [1] TEMPORAL AND TISSUE-SPECIFIC EXPRESSION OF THE MET ORF DRIVEN BY THE COMPLETE TRANSCRIPTIONAL UNIT OF HUMAN A1AT GENE IN TRANSGENIC MICE
    AMICONE, L
    GALIMI, MA
    SPAGNOLI, FM
    TOMMASINI, C
    DELUCA, V
    TRIPODI, M
    [J]. GENE, 1995, 162 (02) : 323 - 328
  • [2] GENE-EXPRESSION IN HEPATOCYTE-LIKE LINES ESTABLISHED BY TARGETED CARCINOGENESIS IN TRANSGENIC MICE
    ANTOINE, B
    LEVRAT, F
    VALLET, V
    BERBAR, T
    CARTIER, N
    DUBOIS, N
    BRIAND, P
    KAHN, A
    [J]. EXPERIMENTAL CELL RESEARCH, 1992, 200 (01) : 175 - 185
  • [3] BARDELLI A, 1996, EMBO J, V15, P6025
  • [4] CELL-DEATH AND CONTROL OF CELL-SURVIVAL IN THE OLIGODENDROCYTE LINEAGE
    BARRES, BA
    HART, IK
    COLES, HSR
    BURNE, JF
    VOYYODIC, JT
    RICHARDSON, WD
    RAFF, MC
    [J]. CELL, 1992, 70 (01) : 31 - 46
  • [5] MOLECULAR THEMES IN ONCOGENESIS
    BISHOP, JM
    [J]. CELL, 1991, 64 (02) : 235 - 248
  • [6] IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT
    BOTTARO, DP
    RUBIN, JS
    FALETTO, DL
    CHAN, AML
    KMIECIK, TE
    VANDEWOUDE, GF
    AARONSON, SA
    [J]. SCIENCE, 1991, 251 (4995) : 802 - 804
  • [7] HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH
    BUSSOLINO, F
    DIRENZO, MF
    ZICHE, M
    BOCCHIETTO, E
    OLIVERO, M
    NALDINI, L
    GAUDINO, G
    TAMAGNONE, L
    COFFER, A
    COMOGLIO, PM
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 629 - 641
  • [8] REGULATED EXPRESSION OF 3 C/EBP ISOFORMS DURING ADIPOSE CONVERSION OF 3T3-L1 CELLS
    CAO, ZD
    UMEK, RM
    MCKNIGHT, SL
    [J]. GENES & DEVELOPMENT, 1991, 5 (09) : 1538 - 1552
  • [9] EXPRESSION OF FETAL AND NEONATAL HEPATIC FUNCTIONS BY MOUSE HEPATOMA RAT HEPATOMA HYBRIDS
    CASSIO, D
    WEISS, MC
    [J]. SOMATIC CELL GENETICS, 1979, 5 (06): : 719 - 738
  • [10] APOPTOSIS, SENESCENCE, IMMORTALIZATION AND CANCER
    CHIARUGI, V
    MAGNELLI, L
    RUGGIERO, M
    [J]. PHARMACOLOGICAL RESEARCH, 1994, 30 (04) : 301 - 315